BBOT — BridgeBio Oncology Therapeutics Inc. stock price, charts and financials

QT35BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc. (NASDAQ: BBOT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.77
-0.12-2.45%
OverviewShort InterestFilings
BBOTQT35BridgeBio Oncology Therapeutics Inc.·NASDAQ
4.77-2.45%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 14, 20264Statement of changes in beneficial ownership
Sep 10, 2026EFFECTNotice of effectiveness
Sep 08, 2026EFFECTNotice of effectiveness
Sep 08, 20268-KCurrent report
Sep 01, 2026POS AMPost-effective amendment
Sep 01, 2026S-3Shelf registration statement
Aug 12, 2026424B3Prospectus
Aug 11, 202610-QQuarterly report
Aug 11, 20268-KCurrent report
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 22, 2026424B3Prospectus
Jun 22, 20268-KCurrent report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
May 13, 2026424B3Prospectus
#1 / 25 of 167
Page
▼
/ 7